• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
  • 0Shopping Cart
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

Scott Gottlieb

NCCS Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner

March 15, 2017/in Cancer News, Cancer Policy Blog, NCCS News Access to Care, Clinical Trials, Payment Reform, Quality Cancer Care, Survivorship Care NCCS News /by actualize
Scott Gottlieb

Scott Gottlieb, MD
Nominee for FDA Commissioner
Resident Fellow, American Enterprise Institute

The National Coalition for Cancer Survivorship (NCCS) applauds the nomination of Dr. Scott Gottlieb for commissioner of the Food and Drug Administration (FDA). Dr. Gottlieb’s experience as a physician, a policymaker, and a patient uniquely qualifies him to lead the FDA at this important time. The agency confronts a rich pipeline of new products for cancer and other illnesses, and these products raise complicated scientific and clinical issues. FDA must also implement the provisions of the 21st Century Cures Act in a way that assures strong review procedures and that further incorporates patient voices. As patient advocates, we believe Dr. Gottlieb can lead the outstanding professional staff at FDA to meet these challenges.

Throughout its history, NCCS has advocated for an efficient cancer drug review process that considers the needs of cancer patients while ensuring that products approved by the FDA are safe and effective and will help patients survive longer and live well with cancer.

“As a physician and cancer survivor, Dr. Gottlieb understands the human toll cancer takes on individuals and families, during both treatment and long-term survivorship,” said Shelley Fuld Nasso, NCCS Chief Executive Officer. “He is open to a wide range of perspectives, including those of the patients whose lives depend on a strong FDA. We look forward to working with him as a partner at the FDA to ensure cancer patients have access to safe and effective treatments.”

Dr. Gottlieb is an NCCS Cancer Policy Advisor, has collaborated with NCCS to host a policy discussion on strategies to put patients first in payment reform efforts, and has been a frequent presenter at NCCS Cancer Policy Roundtable meetings.

About the National Coalition for Cancer Survivorship

Founded by and for cancer survivors in 1986, the National Coalition for Cancer Survivorship advocates to transform the cancer care system for all touched by cancer, from the moment of diagnosis. A voice for cancer survivors and their families in Washington, DC, NCCS’ vision is cancer care that supports survivors and their families, that is affordable and accessible, and that considers individuals’ goals and values.


Tags: cancer care, clinical trials, drug approvals, FDA, patient first, payment reform
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2017/03/Scott-Gottlieb.jpg 428 640 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2017-03-15 16:56:562017-03-15 16:56:56NCCS Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner
You might also like
inflammatory breast cancer Guest Post: For the Love of a Friend
FacebookProfile3 Medicare Proposal to Cover Advance Care Planning Conversations Marks an Important Step toward Patient-Centered Care
New York Times Thumbnail Dr. Ezekiel J. Emanuel Opinion Piece “We Can Be Healthy and Rich”
Snyder Video Post: Dr. Claire Snyder Discusses How Patient-Reported Outcomes Can Improve Cancer Care
journeyforward Two Free Apps Help Manage Cancer Symptoms and Coordinate Care
Fotolia 23428619 S e1461260836640 NCCS Comments on the FDA’s PDUFA Proposed Commitment Letter
NCCS Starburst Thumbnail WCOE: Cancer Causing Infections, the Uncertainty of Prognosis, A Grim Breast Cancer Milestone for Black Women, Important Healthcare Marketplace Dates, and the Financial Toll of Cancer
Discusses the Pros and Cons of BRCA Screening WCOE: Medicare’s Draft Decision for Lung Cancer Screenings, Immunotherapy, Breast Cancer Screening

Latest News

HHS Humphrey bldg 1200

NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care

December 22, 2020
The National Coalition for Cancer Survivorship (NCCS) joined other member organizations…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-22 20:27:262021-01-04 21:38:15NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care
NCCS Letter to HHS

NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients

December 9, 2020
The National Coalition for Cancer Survivorship (NCCS) recently submitted comments…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200-1030x515-1.jpg 515 1030 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-09 17:30:502020-12-10 08:22:55NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients
HHS Humphrey bldg 1200

NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

December 3, 2020
The National Coalition for Cancer Survivorship (NCCS) opposes the Most Favored Nation…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-03 21:26:462020-12-03 21:28:06NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

NCCS Statement on CBO Score of the American Health Care Act (AHCA) ProtectOurCare 1024px ProtectOurCare 1024px ACA Update | March 17, 2017: The AHCA CBO Score, a Cancer Survivor’s Question...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute